Search

everythinglearnresearchcommunity

for

Search:↓

Frontal fibrosing alopecia can cause sudden hair loss on limbs, similar to scalp hair loss.

Stress in mice delays hair growth and treatments blocking substance P can partly reverse this effect.

The article concludes that developing in vitro models for human hair structures is important for research and reducing animal testing, but there are challenges like obtaining suitable samples and the models' limitations.

The model suggests that scalp tension could lead to hair loss, with factors like blood vessel hardening, enlarged oil glands, and poor microcirculation also playing a role. It also hints at a possible link between skull shape and baldness pattern.

Acanthosis nigricans is a skin condition that may indicate a higher risk for insulin resistance and type 2 diabetes, and more research is needed to understand and treat it.

TPA promotes hair growth by increasing stem cell activity and activating specific cell signals.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Enzyme replacement therapy improved multiple symptoms of homocystinuria in mice.

Hair can regrow in large wounds through a process similar to how hair forms in embryos, and understanding this could lead to new treatments for hair loss or scarring.

Nanomaterials in biomedicine can improve treatments but may have risks like toxicity, needing more safety research.

People with Lichen Planus, especially with mucosal involvement, are more likely to have Metabolic Syndrome, which increases their risk for heart disease and diabetes.

Astaxanthin is a safe antioxidant that may improve heart, skin, eye health, and physical performance, and help manage chronic diseases.

Safflower has been used in traditional medicine for centuries and shows promise in treating heart, brain, and inflammatory conditions, but more research is needed to ensure its safety.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Cheonggukjang may help prevent and manage various diseases and improve overall health, but its odor and safety concerns need addressing.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

AIRE-deficient rats developed severe autoimmune disease similar to APECED, useful for testing treatments.

Autoimmune liver diseases are likely linked to certain skin conditions like vitiligo and psoriasis.

Antidepressants might help with skin inflammation and improve conditions like psoriasis and eczema.

New drugs for heart disease may be developed from molecules secreted by stem cells.

Women with PCOS have higher xanthine oxidase activity linked to inflammation and heart disease risks.

Topical vitamin D is useful for some skin conditions but not effective for others, and more research is needed.

Dying cells can help with faster healing and new hair growth by releasing a growth-promoting molecule.

Using anabolic androgenic steroids can cause serious, lasting health problems in many parts of the body.

Skin aging is caused by stem cell damage and can potentially be delayed with treatments like antioxidants and stem cell therapy.

Some growth factors, while important for normal body functions, can cause diseases when not regulated properly.

CRTH2 antagonists might be useful for treating many conditions because they play a role in immune and inflammation responses.

The hair keratin gene KRT81 is found in both normal and breast cancer cells and helps them invade surrounding tissues.